glp-1 drugs cancer Linked to Dramatically Lower Death Rates in Colon Patients Does Using GLP-1 Drugs, Like
Description
The higher dose also achieved slightly better glycemic control, reductions in cardiometabolic risk, and improved physical function relative to the standard dose
The trial used fixed naltrexone doses (4.5 mg daily) paired with semaglutide up to 2.4 mg weekly
Mendes FF, Carvalho LIM, Lopes MB
Presse Med
